ESC 365 - Effects of once-weekly exenatide on clinical outcomes in the subgroup of patients with pre-existing cardiovascular disease: insights from EXSCEL

ESC Premium Access

Effects of once-weekly exenatide on clinical outcomes in the subgroup of patients with pre-existing cardiovascular disease: insights from EXSCEL

Session: Management of coronary disease: temporal trends and residual risk

Topic: Clinical

Speaker: Doctor R. Mentz (Durham, US)

Event: ESC Congress 2018

Congress Presentation

About the speaker

Doctor Robert Mentz

Duke University Medical Center, Durham (United States of America)

9 presentations

0 follower

6 more presentations in this session

Trends and outcomes of use of coronary angiography in management of non-ST-Elevation acute coronary syndromes (NSTEACS), a population based cohort study

Speaker: Doctor M. Rashid (Stoke-on-Trent, GB)

Continuing decline in incidence of recurrent myocardial infarction, stroke, and death following first myocardial infarction: a 15-year nationwide cohort study

Speaker: Doctor T. Sehested (Copenhagen, DK)

Patterns and temporal trends of comorbidity among adult patients with incident cardiovascular disease in the UK between 2000 and 2014: a population-based cohort study

Speaker: Doctor J. Tran (Oxford, GB)

Linear ongoing risk of major cardiovascular events in a global prospective registry of high-risk patients with stable coronary disease: insights from the TIGRIS study

Speaker: Professor D. Brieger (Sydney, AU)

Identifying higher risk patients among the COMPASS-Eligible population: An analysis from the REduction of atherothrombosis for continued health (REACH) Registry

Speaker: Doctor A. Darmon (Paris, FR)

Access the full session

Management of coronary disease: temporal trends and residual risk

Speakers: Doctor R. Mentz, Doctor M. Rashid, Doctor T. Sehested, Doctor J. Tran, Professor D. Brieger...

About the event

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by